BMP4 and metabolic dysfunction-associated steatohepatitis: To further verify the effects of increased BMP4 levels on NASH progression, the NASH phenotype was tested by overexpressing BMP4 or adding exogenous rhBMP4 to FFA-treated hepatocytes.